Clinical Trials Directory

Trials / Completed

CompletedNCT04038827

Origin of CEC in Patients After Allo-HSCT

Search of Circulating Endothelial Cells of Donor Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Evaluation for Potential Clinically Relevant Implications in the Context of Graft-Versus-Host Disease

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

We believe that CEC, besides coming from cells shedding from patient vasculature, could partly belong to donor, originating from the cellular graft.

Detailed description

In consideration of the fact that the vascular endothelium has been shown to be a target of GvHD in early stage and that the count of CEC represent a marker of endothelial damage, we want to correlate the presence of donor CEC at engraftment with a putative protective function against GVHD manifestations. We will enroll patients affected by hematologic disorders undergoing allo-HSCT. At time of engraftment and at + 3 months after allo-HSCT, CEC identified and counted by means of the CellSearch system, will be recovered from the counting cartridge and further sorted at the single cell level. STR profile of each single CEC recovered will be performed in order to define host versus donor origin of each CEC analysed. Through the conduct of this study, we expect to upfront identify patients who will or will not manifest GvHD. This result will allow definitely different clinical approaches: stringent monitoring and early therapeutic intervention, before refractory disease's development, in the formers, while, sparing unnecessarily expensive testing or heavier treatment in the latters.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTD-CEC countingBy means of preliminary bulk separation step with the CellSearch system, single CEC will be sorted

Timeline

Start date
2019-08-27
Primary completion
2020-01-31
Completion
2020-04-30
First posted
2019-07-31
Last updated
2020-07-08

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04038827. Inclusion in this directory is not an endorsement.